Showcase Sponsor

Kineta, Inc. is a biotechnology company focused on the development of new, targeted immune modulating drugs. We are developing five drug and vaccine programs focused on autoimmune diseases, antivirals and chronic pain. Kineta’s corporate strategy is to discover novel compounds, advance them through early stage development then partner with larger biopharma companies to conduct late stage development and commercialization. Our progressive business model is aimed at accelerating advancement of novel medicines to benefit patients and investors more quickly than traditional models.